Dublin, May 28, 2018 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousand by the following Applications:
- Infectious Disease Testing
- Blood Screening
- Cancer Screening
- Other Applications
The report profiles 137 companies including many key and niche players such as:
- Abbott Laboratories (USA)
- Abbott Molecular (USA)
- Becton, Dickinson and Company (USA)
- bioMrieux SA (France)
- Cepheid (USA)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Grifols International, S.A. (Spain)
- Hologic, Inc. (USA)
- QIAGEN N.V. (The Netherlands)
- QuestDiagnostics, Inc. (USA)
- Siemens Healthcare GmBH (Germany)
- Tecan Group Ltd. (Switzerland)
- The ELITechGroup (France)
- Thermo Fisher Scientific (USA)
Key Topics Covered:
1. GLOBAL MARKET OVERVIEW Global In-Vitro Diagnostics (IVD) Market on a Steady Growth Path Molecular Diagnostics A Rapidly Expanding Segment of the IVD Market PCR Technology Leads the MDx Market Current and Future Analysis Leading Players US and Europe Leaders in Molecular Diagnostics Adoption Developing Countries Excel in Growth Prospects Major Growth Drivers Key Market Trends in a Nutshell Major Technology Trends Oncology Molecular Diagnostics to Witness Rapid Growth Reagents and Kits Dominate the Molecular Diagnostics Market Based on Test Location Product Innovations Rife in POC Molecular Diagnostics Market Advancements in Molecular Diagnostics A Boon for the Industry Major Challenges Market Outlook 2. GROWTH DRIVERS AND MARKET TRENDS Aging Population Drives Molecular Diagnostics Market Global Aging Population Statistics Opportunity Indicators Technological Innovations Set to Drive the Market The Role of Molecular Diagnostics in Personalized Medicine Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area Companion Diagnostics Drive Personalized Medicine List of FDA Approved Complementary and Companion Diagnostic Assays Biomarkers as Companion Diagnostics Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth Proteomics Technologies: Growing in Significance New Developments in Proteomics Technologies New Applications Hold Promising Potential Molecular Diagnostics for Lymphoid Malignancies Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum Select NGS Platforms Available in the Market Rising Emphasis on Lab Automation to Augur Well for Market Growth List of Fully Automated and Rapid Molecular Diagnostics Molecular Diagnostics and Intellectual Property Molecular Diagnostics Moving from Centralization to Decentralization Limited Reimbursements by Third Party Payers A Stumbling Block 3. APPLICATION AREAS OF MOLECULAR DIAGNOSTICS Infectious Diseases Bright Prospects Ahead for Molecular Diagnostics for Testing Infectious Diseases Leading Players Key Trends Increasing Incidence of Infectious Diseases Fuels Adoption Rising Incidence of Hospital Acquired Infections Propels Market Growth Rising HIV Prevalence Provides Ample Growth Opportunities Infectious Disease Testing A Major Driver of Molecular Diagnostics Market Select FDA-Cleared Molecular Diagnostic Tests for Infectious Diseases Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market List of Select HPV Molecular Diagnostic Tests by Company and Technique Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing Major Risk Factors to HPV/Cervical Cancer HPV Testing for Primary Screening Indication Bodes Well for the Market's Growth Archaic TB Diagnostic Methods Opens Up Opportunities for Molecular Diagnostics List of Select Commercially-Available TB Diagnostics An Overview of Select TB Diagnostics Molecular POC Testing for Infectious Diseases: Yet to Realize Its Full Potential PCR Plays a Vital Role in the Diagnosis of Infectious Diseases Blood Screening Molecular based Tests Ingrain Roots in Blood Donor Screening Segment Cancer Screening & Diagnosis Overview Molecular Tests Lead the Way for Cancer IVD Market Growth Molecular Markers to Enhance Thyroid Cancer Diagnosis Oncology-Based Molecular Diagnostics: The Propitious Segment List of US-FDA Approved Biomarkers for Cancer Growing Popularity of Chemo-Sensitivity Testing of CTCs Cervical Cancer Screening: Focus on Detection of CIN2 and CIN3 Cancers Other Testing Applications Genetic Disease Testing Applications Overview Pharmacogenomics Prognosis Based on Genomics Pharmacogenomics Development Augurs Growth of Genetic Testing Market Prospects for Genetic Diagnostics and Testing Grow Brighter List of Select FDA-Cleared Genetic Tests by Disease Genetic Testing An Indispensible Tool for Cystic Fibrosis Table 19: Most Common Mutations and Worldwide Frequency (includes corresponding Graph/Chart) Genetic Testing Plays Pivotal Role in Diagnosing Inherited Conditions Non-Invasive Prenatal Diagnostics The Way Ahead Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents 4. COMPETITION IN THE MOLECULAR DIAGNOSTICS MARKET An Overview of Competitive Landscape in Molecular Diagnostics Global Molecular Diagnostics Market by Leading Player (2017): Percentage Share Breakdown by Value Sales for Roche, Qiagen, Abbott, GenProbe, Siemens, and Others Other Noteworthy Companies Cepheid: Unquestioned Leader in the Rapid and Automated MDx Market Qiagen: The Leading Player in the Global HPV MDx Market Comparative Analysis of Select HPV MDx Tests Competitive Dynamics in the C. difficile Testing Market Global Molecular Diagnostics Market for Clostridium difficile by Leading Player (2017): Percentage Breakdown of Revenues for Becton Dickinson, Cepheid, Meridian, and Others List of Select Molecular C. difficile Test Products Competition in the Blood Screening MDx Market Global Blood Screening MDx Market by Leading Players (2017): Percentage Market Share Breakdown of Value Sales for Grifols, Roche, and Others Pharmaceutical Firms Carving Their Niche in Molecular Diagnostic Market Competitive Landscape in the Global RT-PCR Market Leading Players in Global RT-PCR Instruments Market (2017): Percentage Breakdown of Value Sales for Life Sciences Research by Leading Players - Thermo Fischer, Bio-Rad, Roche, Agilent, Qiagen and Others Select Real-Time PCR Products by Company Competition Heats Up in dPCR Market Life Sciences Companies Eye on Lucrative Prostate Cancer MDx Market Consolidation Activity Continues to Strengthen Driven by New Entrants Major M&A Transactions in Molecular Diagnostics: 2011-2018 5. PRODUCT & TECHNOLOGY OVERVIEW Molecular Diagnostics Definition & Scope Molecular Diagnostics Impact on Healthcare Utility of Molecular Diagnostic Tests Background of Molecular Diagnostics Types of Molecular Diagnostics Conventional Diagnostics Vs. Molecular Diagnostics Unabated Developments in Molecular Diagnostics Technology Signal Amplification Technologies PCR New Developments Quantitative Real-Time PCR for Molecular Diagnostics Signal Detection and Quantification Quantitative Real-Time RT-PCR Analysis Applications of Quantitative Real-Time PCR Analysis Digital PCR Non-PCR Methods Other Signal Amplification Technologies DNA Probe Based Products Direct Detection of Specific Nucleic Acid Sequences Nucleic Acid Amplification and Detection DNA Sequencing and Gene Detection Arrays of Immobilized Probes (DNA Chips) in Gene Detection RNA Diagnostics Complementary Molecular Diagnostic Technologies Fluorescent In-Situ Hybridization (FISH) DNA Biochips/Microarrays Biosensors Proteomic Technologies for Molecular Diagnostics Nanotechnology for Molecular Diagnostics Technologies on the Anvil Haplotype Analysis A Distant Possibility Chronic Multi-Gene Defects Now Diagnosable Whole Genome Sequencing A Boon or a Bane to Genetic Testing? 6. PRODUCT APPROVALS/INTRODUCTIONS Mobidiag Unveils Novodiag Solution QIAGEN Unveils QFT-Plus Interpace Diagnostics Launches Lung Cancer Test Selfdiagnostics Introduces STD Multitest Multiplicom Releases Extended CE-IVD Certification for all BRCA Testing Needs Admera Health Introduces OncoGxSelect at the AMP 2016 Annual Meeting Interpace Diagnostics Launches Two New Thyroid Services Abbott Completes the Launch of Alinity Bio-Rad Introduces Amplichek I Quality Control Qiagen Introduces New Diagnostic Test for Cervical Cancer GE Showcases Discovery MI and Discovery NM/CT 670 CZT Quest Launches New Tests for Determining Hereditary Cancer Predictive Launches Test for Spine Deformities LabCorp Introduces Epi proColon Agena Rolls Out MassARRAY Dx Rosetta Introduces Three New Diagnostic Offerings 7. RECENT INDUSTRY ACTIVITY Randox Partner with Bosch to Introduce Vivalytic Eurofins Acquires NMDL-LCPL QIAGEN N.V Acquires STAT-Dx Siemens Healthineers Acquires Fast Track Diagnostics General Atomics Buys Assets of Xagenic, Inc QIAGEN Establish Custom Solutions Business Abbott Acquires Alere, Inc Biocartis Extends Partnership with ETPL Agilent Technologies Signs Agreement with Agendia on Molecular Cancer Diagnostics AID Partners Capital Takes over Israeli Medical Diagnostic Agilent Technologies Acquires Multiplicom N.V ELITechGroup agrees with Abbott's Molecular Business, for Distributing Molecular Diagnostic Reagents Miragen Therapeutics and Signal Genetics Agrees to Merge New England Biolabs Agrees with AmpTec GmbH for Supplying key mRNA Synthesis Reagents Seegene and Hamilton Signs Agreement for Developing Molecular Diagnostics System Transgenomic and Precipio Diagnostics Agrees to Merge Sedia Biosciences and Floragenex Completes Merger Interpace Diagnostics Group Completes the Launch of PanDNA WuXi AppTec's Laboratory Testing Division Enters into a Distributor Agreement with AutoGenomics Danaher Corporation Enters into Merger Agreement with Cepheid Interpace Diagnostics Group, Inc. Extends Agreement with LabCorpLH Agilent Technologies Agrees with Burning Rock to Develop Cancer Diagnostics in China Bio-Techne to Acquire Advanced Cell Diagnostics Myriad Acquires Sividon Diagnostics Siemens Acquires Neo New Oncology Luminex to Acquire Nanosphere DiaSorin Completes Acquisition of Focus Diagnostics Avant Acquires Amarantus Diagnostics HTG to Collaborate With Bristol-Myers Squibb Miroculus to Acquire Kapplex Cepheid's Xpert MRSA NxG Gets European Approval SpeeDx Collaborates with Goffin Molecular FDA Approves BD's Totalys BioFire Diagnostics' FilmArray Obtains CE Mark Approval Thermo Fisher Acquires Affymetrix Qiagen Collaborates with Mirati BioGenex to Commence Operations from India Center Illumina Collaborates with investors to Launch GRAIL 8. FOCUS ON SELECT GLOBAL PLAYERS 9. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 137 (including Divisions/Subsidiaries 158)
- North America
- The United States (95)
- Canada (3)
- Japan (1)
- Europe (47)
- France (5)
- Germany (11)
- The United Kingdom (9)
- Italy (2)
- Spain (1)
- Rest of Europe (19)
- Asia-Pacific (Excluding Japan) (11)
- Middle East (1)
For more information about this report visit https://www.researchandmarkets.com/research/s...cular?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Molecular Diagnostics
